Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MANCOL Study
2012-003398-24Phase 3Active
- Sponsor
- Fundació Puigvert
- Start
- Sep 2012
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of Bronchitol in renal mass and hypovolemia (3 arms), sponsored by Fundació Puigvert. Primary endpoint: Glomerular filtration rate at 6 months. Started Sep 2012; status: active.
02
Drugs
Bronchitol
03
Conditions
renal masshypovolemia
Beyond the preview
Go deeper on 2012-003398-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003398-24.